Company Quick10K Filing
Arcadia Biosciences
10-Q 2020-06-30 Filed 2020-08-13
10-Q 2020-03-31 Filed 2020-05-13
10-K 2019-12-31 Filed 2020-03-25
S-1 2019-12-11 Public Filing
10-Q 2019-09-30 Filed 2019-11-06
S-1 2019-07-26 Public Filing
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-04-01
S-1 2018-12-27 Public Filing
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-20
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-08
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-03-08
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-11
10-Q 2015-03-31 Filed 2015-06-25
8-K 2020-08-13 Earnings, Exhibits
8-K 2020-07-06 Enter Agreement, Sale of Shares
8-K 2020-07-06 Enter Agreement, Sale of Shares, Exhibits
8-K 2020-06-26 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2020-06-01
8-K 2020-05-14
8-K 2020-05-14
8-K 2020-05-13
8-K 2020-04-16
8-K 2020-03-25
8-K 2019-11-06
8-K 2019-09-27
8-K 2019-09-11
8-K 2019-09-05
8-K 2019-08-22
8-K 2019-08-14
8-K 2019-08-05
8-K 2019-06-12
8-K 2019-06-03
8-K 2019-05-20
8-K 2019-05-08
8-K 2019-03-27
8-K 2019-02-28
8-K 2019-02-13
8-K 2018-11-07
8-K 2018-08-08
8-K 2018-07-31
8-K 2018-06-11
8-K 2018-06-06
8-K 2018-05-12
8-K 2018-05-09
8-K 2018-05-07
8-K 2018-05-02
8-K 2018-03-20
8-K 2018-03-19
8-K 2018-01-19

Arcadia Biosciences Financials

RKDA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
CF Industries (CF) 10,824,625 25% 9.6 4% 12,902,000 9,922,000 4,673,000 1,189,000 552,000 1,510,000 14,555,625
Mosaic (MOS) 7,690,725 12% 18.6 -1% 20,440,100 10,339,700 6,830,000 816,600 -139,500 621,400 11,565,425
Israel Chemicals (ICL) 7,463,975 0% 8,776,000 4,861,000 0 0 0 0 7,463,975
Scotts Miracle-Gro (SMG) 5,760,616 32% 10.0 15% 3,028,700 2,305,500 3,156,000 1,019,500 460,700 739,300 7,407,916
American Vanguard (AVD) 462,244 39% 15.1 3% 681,297 343,311 469,002 183,801 17,581 41,138 621,364
CVR Partners (UAN) 451,999 14% 20.6 -1% 1,180,322 727,966 416,233 58,732 -11,458 48,486 999,852
Marrone (MBII) 212,112 53% -5.9 -50% 78,320 53,763 21,107 11,194 -39,332 -37,472 221,152
Calyxt (CLXT) 197,533 -13% -3.9 -35% 96,410 24,281 3,153 -411 -33,995 -33,251 129,583
Evogene (EVGN) 80,611 0% 58,694 0 0 0 0 78,542
Senestech (SNES) 28,288 27% -3.6 -110% 6,554 1,406 79 21 -7,238 -6,924 24,639
China Green Agriculture (CGA) 23,494 21% -7.8 -1% 463,098 80,644 287,188 61,332 -4,737 7,650 -59,460
Arcadia Biosciences (RKDA) 2,248 0% 0.8 -60% 37,302 23,069 753 0 -22,561 -22,409 -18,180
Pacific Ethanol (PEIX) 28 -3% -7.4 -12% 652,860 380,345 1,067,264 -34,155 -79,872 -30,392 225,492
Aemetis (AMTX) 21 5% -15.2 -33% 96,683 243,435 149,896 6,904 -31,823 -12,871 196,229
Real Goods Solar (RGSE) 15 0% 0.1 -82% 13,903 9,169 6,681 0 -11,377 -10,999 -784
Posco (PKX) 4 12% 2.6 7% 70 28 209 26 5 8 20
Nutrien (NTR)
Kinross Gold Corporation (KGC)
Bioceres Crop Solutions (BIOX) 0% 242,467 180,372 0 0 0 0 -0

Balance Sheet ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash11,27880,00362,96623,97329,54027,36010,4732,0137,55913,4382,9309,12520,4189,6676,66911,99810,43814,64620,541
Accounts Receivable15014568570658717797349284432731,2315218019316579125127
Inventory5215725982943163063602522422862362293092823541811878391,843
PP&E6636335975,2446566365805,4494864173695,1802802702655,1964606391,283
Assets19,42084,98879,97374,24270,10565,70961,58656,57452,64848,43318,97816,57022,59931,13227,21724,02421,95025,34637,302
Accounts Payable424222366285
Long-Term Debt9,67019,34919,46224,93024,97825,02725,07725,12725,17525,22500000113
Liabilities38,77537,06236,14034,01734,62834,42134,07534,37634,27733,6728,3118,56321,93223,00214,29511,20921,31717,06023,069
Stockholders' Equity-91,87547,92643,83340,22535,47731,28827,51122,19818,37114,76110,6678,0076678,13012,92212,8156338,28613,544
Income Statement ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue8151,4301,8231,3468527211,075-691,01899158932214436370158203392
Cost of Revenue
Gross Profit
R&D1,8322,0863,1791,8692,2022,2162,2551,9901,8231,6691,7492,1661,3961,7941,3341,5051,9501,931
SG&A2,6382,7852,8182,8783,4362,7592,6873,3683,0522,9432,4152,2412,6212,9493,0112,8123,1454,477
Tax22990-97-1966117110813024115190-3
Net Income-5,803-3,677-4,619-3,857-5,190-4,551-4,175-5,708-4,216-4,006-4,525-2,960-10,615-6,6694,450-12,6124,238-14,187
Cash Flow ($'000)2015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-2,598-3,984-4,581-3,946-4,855-3,992-3,931-4,277-4,530-4,387-2,365-2,683-2,617-4,018-3,969-4,460-3,757
Cash Investing-7-16-11,347-34,99010,3281,679-13,111-4,19710,06010,26617,9748,8783,8761,0672,4221,790-5,497
Cash Financing-2,68872,725-1,109-579413315514160-26,117010,034-47-136,87815,149